EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis

Yang Yue, Chengda Wei iD, Mengmeng Ding, Xiuwei Zhang, Xuemei Li, Lu Liu iD, Chengcheng Liu, Ce Wang iD

Journal of the American Heart Association · 07.07.2026 · 15 (13)

DOI: 10.1161/jaha.125.048926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 07.07.2026. Verfasst von Yang Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthodontics, School of Stomatology China Medical University Shenyang Liaoning China. Hauptthemen laut MEDLINE: Myocarditis, Coxsackievirus Infections, Antiviral Agents, Enterovirus B, Human. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coxsackievirus B3 is a primary cause of viral myocarditis, with ≈20% of cases progressing to dilated cardiomyopathy. Despite its clinical significance, therapeutic strategies remain limited. The pathogenesis of coxsackievirus B3–induced myocarditis is complex, centered on the virus's ability to hijack the myocardial microenvironment, which is composed of various cell types and their interactions, influencing disease progression and outcomes. This review comprehensively summarizes the changes in fibroblasts, endothelial cells, mast cells, monocytes/macrophages, neutrophils, dendritic cells, natural killer cells, and lymphocytes within the myocardial microenvironment during coxsackievirus B3 infection, highlighting their critical roles in disease development. Additionally, it provides an overview of recent findings on potential therapeutic approaches targeting the myocardial microenvironment. Targeted regulation of cellular functions, key molecular pathway intervention, intelligent delivery system development, and noninvasive biomarker identification, combined with organoid and artificial intelligence technologies, pave the way for precision therapy and diagnosis centered on myocardial microenvironment remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisCoxsackievirus InfectionsAntiviral AgentsEnterovirus B, HumanCellular MicroenvironmentMyocardiumHumansAnimals

Stichwörter der Autor:innen

Coxsackievirus B3cardiomyocytemechanismmicroenvironmentmyocarditis

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Orthodontics, School of Stomatology China Medical University Shenyang Liaoning China.
  • Department of Anesthesiology Shengjing Hospital of China Medical University Shenyang Liaoning China.
  • Department of Pathology The Fourth Affiliated Hospital of China Medical University Shenyang Liaoning China.
  • Department of Pediatrics Shengjing Hospital of China Medical University Shenyang Liaoning China.
  • Department of Preventive Dentistry, School and Hospital of Stomatology, Liaoning Provincial Key laboratory of Oral Diseases China Medical University Shenyang Liaoning China.
  • Department of Rehabilitation Shengjing Hospital of China Medical University Shenyang Liaoning China.

ORCID-Profile: Chengda Wei, Lu Liu, Ce Wang

Zitieren

APA

Yue, Y., Wei, C., Ding, M., Zhang, X., Li, X., Liu, L., Liu, C., & Wang, C. (2026). Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis. Journal of the American Heart Association, 15(13). https://doi.org/10.1161/jaha.125.048926

Vancouver

Yue Y, Wei C, Ding M, Zhang X, Li X, Liu L, et al. Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis. Journal of the American Heart Association. 2026;15(13). doi:10.1161/jaha.125.048926

BibTeX
@article{Yue2026,
  author = {Yue, Yang and Wei, Chengda and Ding, Mengmeng and Zhang, Xiuwei and Li, Xuemei and Liu, Lu and Liu, Chengcheng and Wang, Ce},
  title = {Targeting the Myocardial Microenvironment: Novel Antiviral Strategies and Therapeutic Perspectives for Coxsackievirus B–Induced Myocarditis},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {13},
  doi = {10.1161/jaha.125.048926}
}
Kostenlos starten →